Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Greig

Showing results (151-160 of 332) with videos related to

Pageof 34
Sort By:
Genes|March 22, 2018
The Role of microRNAs in Alzheimer's Disease and Their Therapeutic PotentialsMunvar Miya Shaik, Ian A Tamargo, Murtala B Abubakar, et al.
Scientific Reports|February 7, 2018
Neuroprotective effects of pifithrin-α against traumatic brain injury in the striatum through suppression of neuroinflammation, oxidative stress, autophagy, and apoptosisYa-Ni Huang, Ling-Yu Yang, Nigel H Greig, et al.
Ageing Research Reviews|May 13, 2024
The seeds of its regulation: Natural antisense transcripts as single-gene control switches in neurodegenerative disordersDebomoy K Lahiri, Bryan Maloney, Ruizhi Wang, et al.
Neurobiology of Disease|November 30, 2010
Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcomeJeong Seon Yoon, Jong-Hwan Lee, Tae Gen Son, et al.
Journal of Neurochemistry|June 19, 2016
Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease modelXin Qi, Brandon Davis, Yung-Hsiao Chiang, et al.
Neurotoxicity Research|May 10, 2019
Pifithrin-Alpha Reduces Methamphetamine Neurotoxicity in Cultured Dopaminergic NeuronsYun-Hsiang Chen, Eunkyung Bae, Hsi Chen, et al.
Current Alzheimer Research|August 31, 2011
N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's diseaseDavid Olivares, Varun K Deshpande, Ying Shi, et al.
Translational Psychiatry|March 4, 2020
Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's diseaseBalmiki Ray, Bryan Maloney, Kumar Sambamurti, et al.
Plos One|December 7, 2013
Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in ratsKatharine Eakin, Yazhou Li, Yung-Hsiao Chiang, et al.
Journal of Biomedical Science|September 10, 2017
Repositioning drugs for traumatic brain injury - N-acetyl cysteine and PhenserineBarry J Hoffer, Chaim G Pick, Michael E Hoffer, et al.
Pageof 34

Showing results (151-160 of 332) with videos related to

Sort By:
Pageof 34
Genes|March 22, 2018
The Role of microRNAs in Alzheimer's Disease and Their Therapeutic PotentialsMunvar Miya Shaik, Ian A Tamargo, Murtala B Abubakar, et al.
Scientific Reports|February 7, 2018
Neuroprotective effects of pifithrin-α against traumatic brain injury in the striatum through suppression of neuroinflammation, oxidative stress, autophagy, and apoptosisYa-Ni Huang, Ling-Yu Yang, Nigel H Greig, et al.
Ageing Research Reviews|May 13, 2024
The seeds of its regulation: Natural antisense transcripts as single-gene control switches in neurodegenerative disordersDebomoy K Lahiri, Bryan Maloney, Ruizhi Wang, et al.
Neurobiology of Disease|November 30, 2010
Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcomeJeong Seon Yoon, Jong-Hwan Lee, Tae Gen Son, et al.
Journal of Neurochemistry|June 19, 2016
Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease modelXin Qi, Brandon Davis, Yung-Hsiao Chiang, et al.
Neurotoxicity Research|May 10, 2019
Pifithrin-Alpha Reduces Methamphetamine Neurotoxicity in Cultured Dopaminergic NeuronsYun-Hsiang Chen, Eunkyung Bae, Hsi Chen, et al.
Current Alzheimer Research|August 31, 2011
N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's diseaseDavid Olivares, Varun K Deshpande, Ying Shi, et al.
Translational Psychiatry|March 4, 2020
Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's diseaseBalmiki Ray, Bryan Maloney, Kumar Sambamurti, et al.
Plos One|December 7, 2013
Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in ratsKatharine Eakin, Yazhou Li, Yung-Hsiao Chiang, et al.
Journal of Biomedical Science|September 10, 2017
Repositioning drugs for traumatic brain injury - N-acetyl cysteine and PhenserineBarry J Hoffer, Chaim G Pick, Michael E Hoffer, et al.
Pageof 34